[Expression characteristics and clinical significance of CD109 in de novo acute myeloid leukemia]

Zhonghua Xue Ye Xue Za Zhi. 2023 Sep 14;44(9):770-774. doi: 10.3760/cma.j.issn.0253-2727.2023.09.012.

[Article in Chinese]

Authors

L X Wang¹, Y Chen¹, S T Dong¹, F G Ren¹, Y F Zhang¹, J M Chang¹, Y H Tan¹, X H Chen¹, H W Wang¹, Z F Xu¹

Affiliation

¹ Department of Haematology, The Second Hospital of Shanxi Medical University, Shanxi Provincial Key Laboratory of Molecular Diagnosis and Treatment of Hematological Diseases, Taiyuan 030001, China.

PMID: 38049323
PMCID: PMC10630576
DOI: 10.3760/cma.j.issn.0253-2727.2023.09.012

No abstract available

MeSH terms

Antigens, CD
Clinical Relevance*
GPI-Linked Proteins
Humans
Leukemia, Myeloid, Acute*
Neoplasm Proteins
Transcription Factors

Substances

Transcription Factors
CD109 protein, human
Neoplasm Proteins
Antigens, CD
GPI-Linked Proteins

Grants and funding

基金项目：山西省留学人员科技活动择优资助项目（20210027）；山西省卫生健康委科研课题（2021056）